Clinical Trial Update: Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on injecting autologous muscle fibers into the urethral sphincter to treat stress urinary incontinence, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Autologous muscle fiber injection into the urethral sphincter (autologous muscle fiber injection)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Urinary Incontinence, Stress | Phase 1, Phase 2 | Status: UNKNOWN